본문 바로가기
KERD
논문KCI 등재

Can Hinokitiol Kill Cancer Cells? Alternative Therapeutic Anticancer Agent via Autophagy and Apoptosis

1

조회

0

다운로드

2

인용

0

참고문헌

키워드

주제분류기타자연과학

초록

Cancer is genetically, metabolically and infectiously induced life threatening disorder showing aggressive growing pattern with invasive tendency. In order to prevent this global menace from jeopardizing human life, enormous studies on carcinogenesis and treatment for chemotherapy resistance have been intensively researched. Hinokitiol (β-thujaplicin) extracted from heart wood of cupressaceous is a well-known bioactive compound demonstrating anti-inflammation, anti-bacteria and anti-cancer effects on several cancer types via apoptosis and autophagy. This study proposed that hinokitiol activates transcription factor EB (TFEB) nuclear translocation for autophagy and lysosomal biogenesis regardless of nutrient condition in cancer cells. Mitophagy and β-catenin translocation into the nucleus under treatment of hinokitiol on non-small cell lung cancer (NSCLC) cells and HeLa cells were investigated. Hinokitiol exerted cytotoxicity on HeLa and HCC827 cells; moreover, artificially induced autophagy by overexpression of TFEB granted imperfect sustainability onto HeLa cells. Taken together, hinokitiol is the prominent autophagy inducer and activator of TFEB nuclear translocation. Alternative cancer therapy via autophagy is pros and cons since the autophagy in cancer cells is related to prevention and survival mechanism depending on nutrition. To avoid paradox of autophagy in cancer therapy, fine-tuned regulation and application of hinokitiol in due course for successful suppressing cancer cells are recommended.

Abstract

Cancer is genetically, metabolically and infectiously induced life threatening disorder showing aggressive growing pattern with invasive tendency. In order to prevent this global menace from jeopardizing human life, enormous studies on carcinogenesis and treatment for chemotherapy resistance have been intensively researched. Hinokitiol (β-thujaplicin) extracted from heart wood of cupressaceous is a well-known bioactive compound demonstrating anti-inflammation, anti-bacteria and anti-cancer effects on several cancer types via apoptosis and autophagy. This study proposed that hinokitiol activates transcription factor EB (TFEB) nuclear translocation for autophagy and lysosomal biogenesis regardless of nutrient condition in cancer cells. Mitophagy and β-catenin translocation into the nucleus under treatment of hinokitiol on non-small cell lung cancer (NSCLC) cells and HeLa cells were investigated. Hinokitiol exerted cytotoxicity on HeLa and HCC827 cells; moreover, artificially induced autophagy by overexpression of TFEB granted imperfect sustainability onto HeLa cells. Taken together, hinokitiol is the prominent autophagy inducer and activator of TFEB nuclear translocation. Alternative cancer therapy via autophagy is pros and cons since the autophagy in cancer cells is related to prevention and survival mechanism depending on nutrition. To avoid paradox of autophagy in cancer therapy, fine-tuned regulation and application of hinokitiol in due course for successful suppressing cancer cells are recommended.

참고문헌 (40)

  1. Wei-Kuang Wang, "Hinokitiol induces autophagy in murine breast and colorectal cancer cells", Environmental Toxicology, 31(1), pp.77~84 (2016), Wiley[DOI]
  2. Saniewski M, "The biological activities of troponoids and their use in agriculture a review", J Hortic Res, 22, pp.5~19 (2014)[DOI]
  3. Glick D, "Autophagy : cellular and molecular mechanisms", J Pathol, 221, pp.3~12 (2010)[DOI]
  4. Mizushima N, "Autophagy : renovation of cells and tissues", Cell, 147, pp.728~741 (2011)[DOI]
  5. Mizushima N, "Autophagy : process and function", Genes Dev, 21, pp.2861~2873 (2007)
  6. Liang XH, "Induction of autophagy and inhibition of tumorigenesis by beclin 1", Nature, 402, pp.672~676 (1999)
  7. Gozuacik D, "Autophagy as a cell death and tumor suppressor mechanism", Oncogene, 23, pp.2891~2906 (2004)
  8. Settembre C, "TFEB links autophagy to lysosomal biogenesis", Science, 332, pp.1429~1433 (2011)[DOI]
  9. Martini-Stoica H, "The autophagy-lysosomal pathway in neurodegeneration : a TFEB perspective", Trends Neurosci, 39, pp.221~234 (2016)[DOI]
  10. Jianbin Zhang, "Curcumin targets the TFEB-lysosome pathway for induction of autophagy", Oncotarget, 7(46), pp.75659~75671 (2016), Impact Journals, LLC[DOI]
  11. Song JX, "A novel curcumin analog binds to and activates TFEB in vitro and in vivo independent of MTOR inhibition", Autophagy, 12, pp.1372~1389 (2016)[DOI]
  12. Jayakumar T, "Hinokitiol inhibits migration of A549 lung cancer cells via suppression of MMPs and induction of antioxidant enzymes and apoptosis", Int J Mol Sci, 19, pp.E939~ (2018)[DOI]
  13. Ouyang WC, "Hinokitiol suppresses cancer stemness and oncogenicity in glioma stem cells by Nrf2 regulation", Cancer Chemother Pharmacol, 80, pp.411~419 (2017)[DOI]
  14. Huang CH, "Hinokitiol exerts anticancer activity through downregulation of MMPs 9", 2 and enhancement of catalase and SOD enzymes : in vivo augmentation of lung histoarchitecture, 2015, pp.20, 17720~17734
  15. Li LH, "Hinokitiol induces DNA damage and autophagy followed by cell cycle arrest and senescence in gefitinib-resistant lung adenocarcinoma cells", PLoS One, 9, pp.E104203~ (2014)[DOI]
  16. Ouyang L, "Plant natural products : from traditional compounds to new emerging drugs in cancer therapy", Cell Prolif, 47, pp.506~515 (2014)[DOI]
  17. Napolitano G, "TFEB at a glance", J Cell Sci, 129, pp.2475~2481 (2016)[DOI]
  18. Tsao YT, "Hinokitiol inhibits melanogenesis via AKT", mTOR signaling in B16F10 mouse melanoma cells, 2016, pp.17, 248~
  19. Lee JH, "AMPK activation mediated by hinokitiol inhibits adipogenic differentiation of mesenchymal stem cells through autophagy flux", Int J Endocrinol, 2018, pp.E2014192~ (2018)[DOI]
  20. Wilken R, "Curcumin : a review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma", Mol Cancer, 10, pp.E12~ (2011)[DOI]
  21. Wu WK, "The autophagic paradox in cancer therapy", Oncogene, 31, pp.939~953 (2012)[DOI]
  22. Gozuacik D, "Autophagy as a cell death and tumor suppressor mechanism", Oncogene, 23, pp.2891~2906 (2004)
  23. Green DR, "Mitochondria and the autophagy-inflammation-cell death axis in organismal aging", Science, 333, pp.1109~1112 (2011)[DOI]
  24. Gomes LC, "During autophagy mitochondria elongate, are spared from degradation and sustain cell viability", Nat Cell Biol, 13, pp.589~598 (2011)[DOI]
  25. Tagaya M, "Regulation of mitochondrial dynamics and autophagy by the mitochondria-associated membrane", Adv Exp Med Biol, 997, pp.33~47 (2017)[DOI]
  26. Palikaras K, "Mechanisms of mitophagy in cellular homeostasis, physiology and pathology", Nat Cell Biol, 20, pp.1013~1022 (2018)[DOI]
  27. Ilias Gkikas, "The Role of Mitophagy in Innate Immunity", Frontiers in Immunology, 9, pp.E1283~ (2018), Frontiers Media SA[DOI]
  28. Wilfinger N, "Novel p53-dependent anticancer strategy by targeting iron signaling and BNIP3L-induced mitophagy", Oncotarget, 7, pp.1242~1261 (2016)[DOI]
  29. M. M. Lipinski, "Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer's disease", Proceedings of the National Academy of Sciences, 107(32), pp.14164~14169 (2010), Proceedings of the National Academy of Sciences[DOI]
  30. Frank Madeo, "Can autophagy promote longevity?", Nature Cell Biology, 12(9), pp.842~846 (2010), Springer Science and Business Media LLC[DOI]
  31. Kim W, "Wnt", beta-catenin signalling : from plasma membrane to nucleus, 2013, pp.450, 9~21
  32. Clevers H, "Wnt", beta-catenin signaling and disease, 2012, pp.149, 1192~1205
  33. MacDonald BT, "Wnt", beta-catenin signaling : components, mechanisms, and diseases, 2009, pp.17, 9~26
  34. Yoshida T, "Three dimensional organoid culture reveals involvement of Wnt b catenin pathway in proliferation of bladder cancer cells", Oncotarget, 9, pp.11060~11070 (2018)[DOI]
  35. Rayan A, "Nature is the best source of anticancer drugs : Indexing natural products for their anticancer bioactivity", Plos One, 12, pp.E0187925~ (2017)[DOI]
  36. Thorburn A, "Autophagy and cancer therapy", Mol Pharmacol, 85, pp.830~838 (2014)[DOI]
  37. Lee TB, "Synergistic anticancer effects of curcumin and hinokitiol on gefitinib resistant non-small cell lung cancer cells", Nat Prod Commun, 13, pp.1667~1671 (2018)[DOI]
  38. Ouyang L, "Programmed cell death pathways in cancer : a review of apoptosis, autophagy and programmed necrosis", Cell Prolif, 45, pp.487~498 (2012)[DOI]
  39. Chan Gao, "Autophagy negatively regulates Wnt signalling by promoting Dishevelled degradation", Nature Cell Biology, 12(8), pp.781~790 (2010), Springer Science and Business Media LLC[DOI]
  40. Zhan T, "Wnt signaling in cancer", Oncogene, 36, pp.1461~1473 (2017)[DOI]

관련 논문AI추천

이 간행물의 다른 논문 (18건)